PARP1 and neoplasm: Edmonds et al. also recently used this compound, albeit at a significantly lower specific activity (<2,200 mCi/μmol), and showed that uptake of this radiotracer in a variety of xenograft tumour models in mice could be correlated with intrinsic PARP-1 expression levels.